SCHEMBL9684857

SCHEMBL9684857

O=C(O)CC1C(=O)N(Cc2ccc(Br)cc2F)C(=O)c2ccccc21

nearest known ligand 0.79

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 7/20 0.79
CHRM5 P08912 1/20 0.47
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CDC25A P30304 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9685013 0.88 AKR1B1 (1.00) AKR1B1CHRM5MEN1CYP1A2CYP2C9
SCHEMBL9535759 0.85 AKR1B1 (0.60) AKR1B1CHRM5MEN1CYP1A2CYP2C9
SCHEMBL8323716 0.79 AKR1B1 (0.54) AKR1B1CHRM5MEN1CYP1A2CYP2C9
SCHEMBL9872084 0.77 AKR1B1 (0.79) AKR1B1CHRM5
SCHEMBL9870040 0.74 AKR1B1 (0.73) AKR1B1CHRM5
SCHEMBL9383937 0.73 AKR1B1 (0.54) AKR1B1CHRM5MEN1KMT2AHSD17B10
SCHEMBL9871059 0.73 APAF1 (0.50) AKR1B1MEN1CYP1A2KMT2AHSD17B10
SCHEMBL9036577 0.72 AKR1B1 (0.50) AKR1B1MEN1CYP1A2CYP2C9KMT2A
SCHEMBL9036089 0.71 AKR1B1 (0.52) AKR1B1CHRM5MEN1CYP1A2CYP2C9
SCHEMBL8320456 0.70 AKR1B1 (0.66) AKR1B1CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5130425-A Antidiabetic agents spiro azetidine-2,4'(1'H)-isoquinoline! 1',3',4(2'H)-triones AMERICAN HOME PRODUCTS CORPORATION (US) 1992-07-14 US disclosed
US-4983613-A Acetamides; treatment of neuropathy, nephropathy, retinopathy or cataracts in diabetic mammals AMERICAN HOME PRODUCTS CORPORATION (US) 1991-01-08 US disclosed